Ghent University Academic Bibliography

Your filters: cql: author="Foong, Yi Chao" or (type any "bookEditor issueEditor" and editor="Foong, Yi Chao")

Add to list
Moderate–high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis

Yi Chao Foong, Daniel Merlo, Melissa Gresle, Katherine Buzzard, Dana Horakova, Eva Kubala Havrdova, Tomas Kalincik, Izanne Roos, Suzanne Hodgkinson, Jeannette Lechner-Scott, et al.

(2026) JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 97(1). p.50-58
Add to list
- Journal Article
- A1
- open access
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD : an international cohort study

Pakeeran Siriratnam, Saif Huda, Anneke Van der Walt, Paul Sanfilippo, Sifat Sharmin, Yi Chao Foong, Wei Zhen Yeh, Chao Zhu, Samia J. Khoury, Tunde Csepany, et al.

(2025) JOURNAL OF NEUROLOGY. 272(5).
Add to list
- Journal Article
- A1
- open access
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD : a multicentre study

Pakeeran Siriratnam, Paul Sanfilippo, Anneke van der Walt, Sifat Sharmin, Yi Chao Foong, Wei Zhen Yeh, Chao Zhu, Samia Joseph Khoury, Tunde Csepany, Barbara Willekens, et al.

(2025) JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 96(4). p.361-369
Add to list
Prevalence of progression independent of relapse activity and relapse-associated worsening in patients with AQP4-IgG-positive NMOSD

Pakeeran Siriratnam, Saif Huda, Anneke van der Walt, Paul G. Sanfilippo, Sifat Sharmin, Yi Chao Foong, Wei Z. Yeh, Chao Zhu, Samia J. Khoury, Tunde Csepany, et al.

(2024) NEUROLOGY. 103(12).
Add to list
- Journal Article
- A1
- open access
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic

Anoushka P. Lal, Yi Chao Foong, Paul G. Sanfilippo, Tim Spelman, Louise Rath, David Levitz, Marzena Fabis-Pedrini, Matteo Foschi, Mario Habek, Tomas Kalincik, et al.

(2024) JOURNAL OF NEUROLOGY. 271. p.5813-5824

Academic Bibliography

Moderate–high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis

Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD : an international cohort study

Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD : a multicentre study

Prevalence of progression independent of relapse activity and relapse-associated worsening in patients with AQP4-IgG-positive NMOSD

A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic

Contents

Support

Contact